# OnCo record nct05879822 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct05879822/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct05879822", "NCT05879822" ;
  schema:name "A Study to Evaluate INCB099280 in Participants With Select Solid Tumors Who Are Immune Checkpoint Inhibitor Naive"@en ;
  schema:description "A phase 2 trial of INCB099280 in advanced solid tumours, run by Incyte Corporation, active and no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct05879822/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05879822> ;
  onco:status "active" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "2" ;
  schema:startDate "2023-10-30" ;
  onco:cancers <https://onco.cc/cancers/metastatic-cancer/> ;
  onco:companies <https://onco.cc/companies/incyte/> .